EQUASENS (EQS.PA) Stock Fundamental Analysis

EPA:EQS • FR0012882389

35 EUR
-0.35 (-0.99%)
Last: Feb 18, 2026, 12:54 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

Taking everything into account, EQS scores 6 out of 10 in our fundamental rating. EQS was compared to 10 industry peers in the Health Care Technology industry. EQS has an excellent profitability rating, but there are some minor concerns on its financial health. EQS has a correct valuation and a medium growth rate. Finally EQS also has an excellent dividend rating. With these ratings, EQS could be worth investigating further for dividend investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • EQS had positive earnings in the past year.
  • In the past year EQS had a positive cash flow from operations.
  • EQS had positive earnings in each of the past 5 years.
  • EQS had a positive operating cash flow in each of the past 5 years.
EQS.PA Yearly Net Income VS EBIT VS OCF VS FCFEQS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

1.2 Ratios

  • With a decent Return On Assets value of 8.82%, EQS is doing good in the industry, outperforming 70.00% of the companies in the same industry.
  • With an excellent Return On Equity value of 15.77%, EQS belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 12.84%, EQS belongs to the top of the industry, outperforming 90.00% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for EQS is significantly above the industry average of 8.41%.
Industry RankSector Rank
ROA 8.82%
ROE 15.77%
ROIC 12.84%
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
EQS.PA Yearly ROA, ROE, ROICEQS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • EQS has a Profit Margin of 16.13%. This is in the better half of the industry: EQS outperforms 80.00% of its industry peers.
  • EQS's Profit Margin has been stable in the last couple of years.
  • With a decent Operating Margin value of 20.02%, EQS is doing good in the industry, outperforming 80.00% of the companies in the same industry.
  • In the last couple of years the Operating Margin of EQS has declined.
  • Looking at the Gross Margin, with a value of 68.81%, EQS is doing worse than 60.00% of the companies in the same industry.
  • In the last couple of years the Gross Margin of EQS has remained more or less at the same level.
Industry RankSector Rank
OM 20.02%
PM (TTM) 16.13%
GM 68.81%
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
EQS.PA Yearly Profit, Operating, Gross MarginsEQS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so EQS is still creating some value.
  • Compared to 1 year ago, EQS has about the same amount of shares outstanding.
  • The number of shares outstanding for EQS has been increased compared to 5 years ago.
  • EQS has a better debt/assets ratio than last year.
EQS.PA Yearly Shares OutstandingEQS.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
EQS.PA Yearly Total Debt VS Total AssetsEQS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • EQS has an Altman-Z score of 3.60. This indicates that EQS is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of EQS (3.60) is better than 70.00% of its industry peers.
  • The Debt to FCF ratio of EQS is 0.98, which is an excellent value as it means it would take EQS, only 0.98 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of EQS (0.98) is better than 70.00% of its industry peers.
  • A Debt/Equity ratio of 0.09 indicates that EQS is not too dependend on debt financing.
  • EQS has a Debt to Equity ratio (0.09) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.98
Altman-Z 3.6
ROIC/WACC1.29
WACC9.95%
EQS.PA Yearly LT Debt VS Equity VS FCFEQS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

  • EQS has a Current Ratio of 1.29. This is a normal value and indicates that EQS is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of EQS (1.29) is worse than 60.00% of its industry peers.
  • EQS has a Quick Ratio of 1.20. This is a normal value and indicates that EQS is financially healthy and should not expect problems in meeting its short term obligations.
  • EQS has a Quick ratio (1.20) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.2
EQS.PA Yearly Current Assets VS Current LiabilitesEQS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • EQS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.90%.
  • The Earnings Per Share has been growing slightly by 5.12% on average over the past years.
  • EQS shows a small growth in Revenue. In the last year, the Revenue has grown by 4.45%.
  • Measured over the past years, EQS shows a small growth in Revenue. The Revenue has been growing by 6.45% on average per year.
EPS 1Y (TTM)-13.9%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%0.43%
Revenue 1Y (TTM)4.45%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%7.39%

3.2 Future

  • EQS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.19% yearly.
  • EQS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.74% yearly.
EPS Next Y11.67%
EPS Next 2Y15.06%
EPS Next 3Y14.19%
EPS Next 5YN/A
Revenue Next Year9.72%
Revenue Next 2Y9.5%
Revenue Next 3Y5.96%
Revenue Next 5Y7.74%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EQS.PA Yearly Revenue VS EstimatesEQS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
EQS.PA Yearly EPS VS EstimatesEQS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 14.58, EQS is valued correctly.
  • Based on the Price/Earnings ratio, EQS is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 27.16, EQS is valued a bit cheaper.
  • Based on the Price/Forward Earnings ratio of 11.53, the valuation of EQS can be described as reasonable.
  • EQS's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. EQS is cheaper than 80.00% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of EQS to the average of the S&P500 Index (28.10), we can say EQS is valued rather cheaply.
Industry RankSector Rank
PE 14.58
Fwd PE 11.53
EQS.PA Price Earnings VS Forward Price EarningsEQS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • EQS's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. EQS is cheaper than 80.00% of the companies in the same industry.
  • 70.00% of the companies in the same industry are more expensive than EQS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 14.23
EV/EBITDA 6.93
EQS.PA Per share dataEQS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • EQS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • EQS has a very decent profitability rating, which may justify a higher PE ratio.
  • EQS's earnings are expected to grow with 14.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.25
PEG (5Y)2.85
EPS Next 2Y15.06%
EPS Next 3Y14.19%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. Dividend

5.1 Amount

  • EQS has a Yearly Dividend Yield of 3.42%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 2.02, EQS pays a bit more dividend than its industry peers.
  • EQS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 3.42%

5.2 History

  • The dividend of EQS is nicely growing with an annual growth rate of 8.00%!
Dividend Growth(5Y)8%
Div Incr Years1
Div Non Decr Years2
EQS.PA Yearly Dividends per shareEQS.PA Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • 51.82% of the earnings are spent on dividend by EQS. This is a bit on the high side, but may be sustainable.
  • The dividend of EQS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP51.82%
EPS Next 2Y15.06%
EPS Next 3Y14.19%
EQS.PA Yearly Income VS Free CF VS DividendEQS.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
EQS.PA Dividend Payout.EQS.PA Dividend Payout, showing the Payout Ratio.EQS.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

EQUASENS

EPA:EQS (2/18/2026, 12:54:53 PM)

35

-0.35 (-0.99%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-05
Earnings (Next)04-29
Inst Owners11.7%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap530.95M
Revenue(TTM)224.73M
Net Income(TTM)36.26M
Analysts83.33
Price Target54.06 (54.46%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.42%
Yearly Dividend1.25
Dividend Growth(5Y)8%
DP51.82%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.25%
PT rev (3m)8.16%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.17%
EPS NY rev (3m)-1.17%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 14.58
Fwd PE 11.53
P/S 2.36
P/FCF 14.23
P/OCF 10.88
P/B 2.31
P/tB 6.65
EV/EBITDA 6.93
EPS(TTM)2.4
EY6.86%
EPS(NY)3.04
Fwd EY8.67%
FCF(TTM)2.46
FCFY7.03%
OCF(TTM)3.22
OCFY9.19%
SpS14.81
BVpS15.16
TBVpS5.27
PEG (NY)1.25
PEG (5Y)2.85
Graham Number28.61
Profitability
Industry RankSector Rank
ROA 8.82%
ROE 15.77%
ROCE 15.76%
ROIC 12.84%
ROICexc 18.12%
ROICexgc 70.2%
OM 20.02%
PM (TTM) 16.13%
GM 68.81%
FCFM 16.6%
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
ROICexc(3y)19.08%
ROICexc(5y)21.2%
ROICexgc(3y)48.92%
ROICexgc(5y)61.81%
ROCE(3y)18.64%
ROCE(5y)19.75%
ROICexgc growth 3Y-28.73%
ROICexgc growth 5Y-12.2%
ROICexc growth 3Y-17.5%
ROICexc growth 5Y-11.29%
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
F-Score7
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.98
Debt/EBITDA 0.32
Cap/Depr 70.06%
Cap/Sales 5.11%
Interest Coverage 250
Cash Conversion 79.48%
Profit Quality 102.89%
Current Ratio 1.29
Quick Ratio 1.2
Altman-Z 3.6
F-Score7
WACC9.95%
ROIC/WACC1.29
Cap/Depr(3y)96.13%
Cap/Depr(5y)118.08%
Cap/Sales(3y)6.18%
Cap/Sales(5y)7.08%
Profit Quality(3y)94.47%
Profit Quality(5y)93.6%
High Growth Momentum
Growth
EPS 1Y (TTM)-13.9%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%0.43%
EPS Next Y11.67%
EPS Next 2Y15.06%
EPS Next 3Y14.19%
EPS Next 5YN/A
Revenue 1Y (TTM)4.45%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%7.39%
Revenue Next Year9.72%
Revenue Next 2Y9.5%
Revenue Next 3Y5.96%
Revenue Next 5Y7.74%
EBIT growth 1Y-7%
EBIT growth 3Y-4.55%
EBIT growth 5Y1.4%
EBIT Next Year55.72%
EBIT Next 3Y25.38%
EBIT Next 5YN/A
FCF growth 1Y-36.45%
FCF growth 3Y-1.08%
FCF growth 5Y8.7%
OCF growth 1Y-30.97%
OCF growth 3Y0.02%
OCF growth 5Y3.18%

EQUASENS / EQS.PA FAQ

What is the ChartMill fundamental rating of EQUASENS (EQS.PA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to EQS.PA.


What is the valuation status of EQUASENS (EQS.PA) stock?

ChartMill assigns a valuation rating of 6 / 10 to EQUASENS (EQS.PA). This can be considered as Fairly Valued.


What is the profitability of EQS stock?

EQUASENS (EQS.PA) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for EQS stock?

The Price/Earnings (PE) ratio for EQUASENS (EQS.PA) is 14.58 and the Price/Book (PB) ratio is 2.31.


What is the expected EPS growth for EQUASENS (EQS.PA) stock?

The Earnings per Share (EPS) of EQUASENS (EQS.PA) is expected to grow by 11.67% in the next year.